Burrows Scott L 4
4 · Aeglea BioTherapeutics, Inc. · Filed Sep 5, 2023
Insider Transaction Report
Form 4
Burrows Scott L
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-09-01+10,121,441→ 10,121,441 totalExercise: $0.58Exp: 2033-09-01→ Common Stock (10,121,441 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase 10,121,441 shares of the Issuer's common stock, one quarter of which will vest and become exercisable on September 1, 2024, with the remaining three quarters vesting in monthly installments over the following three years, subject to the Reporting Person's continued employment with the Issuer.